CohBar Inc.(CWBR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CWBR CohBar Inc.

交易中 12-23 10:17:06 EST 延时

{"stockData":{"symbol":"CWBR","market":"US","secType":"STK","nameCN":"CohBar Inc.","latestPrice":0.54,"timestamp":1734967026448,"preClose":0.54,"halted":0,"volume":29,"delay":15,"floatShares":2481743,"shares":2906926,"eps":-4.369927,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-23 10:17:06 EST 延时","open":0.54,"high":0.54,"low":0.54,"amount":15.791,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-4.369927,"exchange":"EXPERT","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"adjPreClose":0.54,"volumeRatio":0.014805},"requestUrl":"/m/hq/s/CWBR","defaultTab":"news","newsList":[{"id":"2490932776","title":"美国OTC市场Cohbar, Inc.盘中异动 早盘股价大涨13.64%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490932776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490932776?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:54","pubTimestamp":1733756043,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时54分，美国OTC市场Cohbar, Inc.股票出现异动，股价急速拉升13.64%。截至发稿，该股报0.500美元/股，成交量2664股，换手率0.09%，振幅13.64%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209225403a1e0b47f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209225403a1e0b47f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CWBR","BK4139"],"gpt_icon":0},{"id":"2489188884","title":"美国OTC市场Cohbar, Inc.盘中异动 临近收盘急速上涨7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489188884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489188884?lang=zh_cn&edition=full","pubTime":"2024-12-06 04:45","pubTimestamp":1733431530,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日04时45分，美国OTC市场Cohbar, Inc.股票出现波动，股价快速上涨7.89%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120604453098e5acd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120604453098e5acd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CWBR","BK4139"],"gpt_icon":0},{"id":"2488412519","title":"美国OTC市场Cohbar, Inc.盘中异动 早盘大幅跳水8.16%报0.450美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488412519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488412519?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:19","pubTimestamp":1733239153,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时19分，美国OTC市场Cohbar, Inc.股票出现异动，股价快速下挫8.16%。截至发稿，该股报0.450美元/股，成交量1.4596万股，换手率0.50%，振幅12.86%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231913a269aeaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231913a269aeaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CWBR"],"gpt_icon":0},{"id":"2472529296","title":"美国OTC市场Cohbar, Inc.盘中异动 早盘股价大跌6.04%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472529296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472529296?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:46","pubTimestamp":1727876797,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时46分，美国OTC市场Cohbar, Inc.股票出现异动，股价快速下挫6.04%。截至发稿，该股报0.490美元/股，成交量116股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。美国OTC市场Cohbar, Inc.公司简介：CohBar Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022146379f253408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022146379f253408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4132","MBT","BK4532","CWBR","BK4139","BK4569"],"gpt_icon":0},{"id":"2459184927","title":"美国OTC市场Cohbar, Inc.（CWBR.us）盘中异动 股价大涨5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459184927","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459184927?lang=zh_cn&edition=full","pubTime":"2024-08-14 00:35","pubTimestamp":1723566900,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日00时35分，美国OTC市场Cohbar, Inc.股票出现异动，股价快速上涨5.99%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为2.11%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140035009f27f29e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408140035009f27f29e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CWBR","BK4139"],"gpt_icon":0},{"id":"2458517437","title":"美国OTC市场Cohbar, Inc.（CWBR.us）盘中异动 急速跳水24.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458517437","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458517437?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:08","pubTimestamp":1723226884,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日02时08分，美国OTC市场Cohbar, Inc.股票出现波动，股价大幅下挫24.79%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为2.35%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810020804aefe2a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810020804aefe2a88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CWBR"],"gpt_icon":0},{"id":"2453885968","title":"美国OTC市场Cohbar, Inc.（CWBR.us）股价重挫16.84% 市值跌9.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453885968","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453885968?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:13","pubTimestamp":1721830380,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时13分，美国OTC市场Cohbar, Inc.股票出现异动，股价急速下挫16.84%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242213009ee6709c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407242213009ee6709c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CWBR","BK4139"],"gpt_icon":0},{"id":"2450814778","title":"美国OTC市场Cohbar, Inc.（CWBR.us）盘中异动 股价大跌20.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450814778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450814778?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:25","pubTimestamp":1720625102,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时25分，美国OTC市场Cohbar, Inc.股票出现波动，股价大幅跳水20.00%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710232503959f91d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710232503959f91d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CWBR","VRPX"],"gpt_icon":0},{"id":"2450072647","title":"美国OTC市场Cohbar, Inc.（CWBR.us）盘中异动 临近午盘股价大涨25.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450072647","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450072647?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:56","pubTimestamp":1720454160,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时56分，美国OTC市场Cohbar, Inc.股票出现异动，股价急速拉升25.00%。美国OTC市场Cohbar, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。美国OTC市场Cohbar, Inc.公司简介：CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070823560095914d9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070823560095914d9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CWBR","BK4139","VRPX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cohbar.com","stockEarnings":[{"period":"1week","weight":2.1747},{"period":"1month","weight":2.3782},{"period":"3month","weight":1.5833},{"period":"6month","weight":0.6417},{"period":"1year","weight":-0.1173},{"period":"ytd","weight":0.6945}],"description":"CohBar, Inc.CohBar，Inc.于2007年10月19日在特拉华州成立。该公司是一家创新型生物技术公司，也是线粒体治疗药物（MBTs）的研发领导者，这是一种新兴的具有潜力的药物 包括非酒精性脂肪性肝炎（NASH），肥胖症，脂肪肝病（NAFLD），2型糖尿病（T2D），癌症，动脉粥样硬化，心血管疾病和神经退行性疾病等与衰老和代谢功能障碍有关的各种疾病，比如阿尔茨海默病。","exchange":"EXPERT","name":"CohBar Inc.","nameEN":"CohBar Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CohBar Inc.(CWBR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CohBar Inc.(CWBR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CohBar Inc.,CWBR,CohBar Inc.股票,CohBar Inc.股票老虎,CohBar Inc.股票老虎国际,CohBar Inc.行情,CohBar Inc.股票行情,CohBar Inc.股价,CohBar Inc.股市,CohBar Inc.股票价格,CohBar Inc.股票交易,CohBar Inc.股票购买,CohBar Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CohBar Inc.(CWBR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CohBar Inc.(CWBR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}